TriSalus launches exchange offer for Series A Preferred, up to 11.9M common shares

TriSalus Life Sciences, Inc.

Offers up to 11,860,206 common shares in exchange for each share of Series A Convertible Preferred at $4.00 per share based on liquidation preference plus accrued dividends through Aug 10, 2027.
Consent solicitation seeks amendment to automatically convert remaining Preferred after offer closes at a ratio 11.3% lower than exchange offer.
Holders representing ~55% of outstanding Preferred have agreed to tender and consent via Tender and Support Agreements.
Expiration date: 12:01 a.m. ET on July 23, 2025; shares can be withdrawn anytime before.
3,594,002 Preferred shares outstanding as of June 13, 2025; Preferred stock not publicly traded.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.